ストックスクリーナーアプリを入手
1.11
0.45%
0.01
Inovio Pharmaceuticals Inc (INO) 最新ニュース
Inovio Pharmaceuticals(INO) Stock Options Chain | Quotes & News - Moomoo
Inovio Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
INO stock edges up after hours as partner reports success in cervical dysplasia trial - MSN
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
INOVIO PHARMACEUTICALS INC (INO) Stock Chart - ChartMill
Anal Cancer Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - Barchart.com
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm - Morningstar
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio gains on late-stage trial win for DNA shot - MSN
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharma Is Maintained at Neutral by HC Wainwright & Co. - Moomoo
Inovio Shares Fall After Analyst Cut, Traders Wait for FDA Decision - Bez Kabli
INO Maintained by HC Wainwright & Co. -- Price Target Lowered to $2.50 - GuruFocus
H.C. Wainwright lowers Inovio stock price target on share count - Investing.com UK
H.C. Wainwright lowers Inovio stock price target on share count By Investing.com - Investing.com South Africa
H.C. Wainwright Maintains Inovio Pharmaceuticals(INO.US) With Hold Rating, Cuts Target Price to $2.5 - Moomoo
INOVIO Partner Reports Phase 3 Success for HPV Therapy in China - MyChesCo
Inovio Pharmaceuticals shareholders back board as INO-3107 FDA review advances - MSN
Q2 2025 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q4 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q1 2026 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
INOVIO to Participate in Upcoming Scientific and Investor Conferences - marketscreener.com
Rare disease DNA medicine on agenda as INOVIO hits June conferences - Stock Titan
Inovio Pharmaceuticals (INO) Holds Near Support Amid Slight DeclineReversal Setup Alerts - thelegaladvocate.com
Inovio Brass Hit With Suit Over FDA Approval Claims - Law360
Is Inovio Pharmaceuticals (INO) a High-Stakes Bet Ahead of its October PDUFA Date - Kavout
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances - Yahoo Finance
Inovio Pharmaceuticals (INO) Stock Rises on Positive Trial Resul - GuruFocus
Inovio Pharmaceuticals (INO) Shares Rise on Positive Trial Resul - GuruFocus
Inovio gains on late-stage trial win for DNA shot (INO:NASDAQ) - Seeking Alpha
Piper Sandler Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China - Sahm
Positive Phase 3 Results for Inovio (INO) Partnered VGX-3100 in China - GuruFocus
INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial - Stocktwits
ApolloBio reports positive phase 3 results for VGX-3100 in China - Investing.com UK
0.23%
1.04%
大文字化:
|
ボリューム (24 時間):